Short Pulse Width Versus Low Frequency DBS in Parkinson's Disease
NCT ID: NCT05034510
Last Updated: 2023-02-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
25 participants
INTERVENTIONAL
2021-03-20
2024-03-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Short Pulse Width DBS in Parkinson's Disease
NCT03417271
Combined Theta-gamma STN Stimulation for Verbal Fluency in Parkinson Disease
NCT06509048
Deep Brain Stimulation (DBS) Frequency Effects on Gait in Parkinson's Disease(PD)
NCT00993291
A Retrospective Study of the Effects of Different Parameters on Motor Symptoms of PD in Bilateral STN Stimulation
NCT01953718
Impact of Subthalamic Nucleus Deep Brain Stimulation on Pain in Parkinson Disease
NCT02885194
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The aim of this investigation is to compare the effect of low frequency and short pulse width stimulation in patients, who develop axial symptoms during long-term follow-up in chronic conventional STN DBS.
As per protocol, participants will be assessed at baseline with chronic standard stimulation parameters (60 us and 130 Hz) then they will be randomly allocated either to a low-frequency (80Hz) or a low-pulse arm (30 us). The study is designed such that after scheduled re-assessment the participant will be switched from low frequency arm to short pulse width and vice versa according to the crossover nature of protocol design. Both the rating investigator and the participant are blinded to the allocation, whereas an unblinded investigator will modify the parameters according to allocation arm.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Low frequency 80 Hz then short pulse width 30 usec stimulation
Each participant will undergo to low frequency stimulation for 4 weeks, then will switch to short pulse width stimulation paradigm for 4 weeks according to the crossover design.
Deep Brain Stimulation
modification in stimulation parameters
Short pulse width 30 usec then low frequency 80 Hz stimulation
Each participant will undergo to short pulse width stimulation paradigm for 4 weeks, then will switch to low frequency for 4 weeks according to the crossover design.
Deep Brain Stimulation
modification in stimulation parameters
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Deep Brain Stimulation
modification in stimulation parameters
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subthalamic Nucleus Deep Brain Stimulation with chronic conventional stimulation at 60 usec and 130 Hz for at least 3 months
* Movement Disorder Society UPDRS part III 3.11 \>1
* Freezing of Gait Questionnaire item-3 \>1
* Movement Disorder Society UPDRS part III 3.1 \>1
* Montreal Cognitive Assessment \> 26
* No psychiatric disorders
* All patients will be ≥ 18 years of age
* Documented informed consent
Exclusion Criteria
* axial disorders not related to Parkinson's disease
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital of Ferrara
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mariachiara Sensi, PhD
Role: PRINCIPAL_INVESTIGATOR
Azienda Ospedaliero Universitaria di Ferrara
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital of Ferrara - Arcispedale Sant'Anna
Ferrara, Emilia-Romagna, Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
203/2019/Disp/AOUFe
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.